During the past decade, Andromed Leiden conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Andromed Leiden" #1 sponsor was "Kowa Research Europe" with 6 trials, followed by "Medical Research Laboratories International" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored and "Ology Bioservices" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Andromed Leiden" are "Dyslipidemia" (4 trials), "Dyslipidemias" (2 trials), "Hypercholesterolemia" (2 trials), "Type II Diabetes Mellitus" (2 trials) and "Dyspepsia" (1 trials). Many other conditions were trialed in "Andromed Leiden" in a lesser frequency.

Most popular intervention types in "Andromed Leiden" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (6 trials), "Atorvastatin" (3 trials), "Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine with or without an Al(OH)3 adjuvant" (1 trials), "IW-9179" (1 trials) and "Implitapide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Andromed Leiden" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Andromed Leiden". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Andromed Leiden, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Andromed Leiden, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".